M. Heim

The Raf kinase inhibitor BAY 43-9006 reduces cellular uptake of platinum compounds and cytotoxicity in human colorectal carcinoma cell lines

Dirk Strumberg, Dimitris Voliotis, Ulrich Jaehde, 2005, Anti-cancer drugs.

Differential modulation of chemosensitivity to alkylating agents and platinum compounds by DNA repair modulators in human lung cancer cell lines

S. Seeber, M. Heim, M. Müller, 2000, Journal of Cancer Research and Clinical Oncology.

Antitumor effect and potentiation or reduction in cytotoxic drug activity in human colon carcinoma cells by the Raf kinase inhibitor (RKI) BAY 43-9006.

S Seeber, D. Strumberg, S. Seeber, 2003, International journal of clinical pharmacology and therapeutics.